Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
The response to immunotherapy of melanoma patients is heterogeneous. Here, the authors demonstrate that a high expression of the two major components of the immunoproteasome, PSMB8 and PSMB9, modulates the production of HLA peptides and it is predictive of better survival and improved response to im...
Enregistré dans:
Auteurs principaux: | Shelly Kalaora, Joo Sang Lee, Eilon Barnea, Ronen Levy, Polina Greenberg, Michal Alon, Gal Yagel, Gitit Bar Eli, Roni Oren, Aviyah Peri, Sushant Patkar, Lital Bitton, Steven A. Rosenberg, Michal Lotem, Yishai Levin, Arie Admon, Eytan Ruppin, Yardena Samuels |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c5c1da08d4014458bca5479e40d5cf1c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
On the Role of the Immunoproteasome in Protein Homeostasis
par: Michael Basler, et autres
Publié: (2021) -
20S immunoproteasomes remove formaldehyde-damaged cytoplasmic proteins suppressing caspase-independent cell death
par: Sara Ortega-Atienza, et autres
Publié: (2017) -
Corneal wound healing is compromised by immunoproteasome deficiency.
par: Deborah A Ferrington, et autres
Publié: (2013) -
mTORC1 accelerates retinal development via the immunoproteasome
par: Ji-Heon Choi, et autres
Publié: (2018) -
Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytes
par: Ruda de Luna Almeida Santos, et autres
Publié: (2017)